Collectively, smallholder poultry farmers around the world provide a large market for livestock veterinary products. But this crucial segment has traditionally been unserved by pharmaceutical companies, often because smallholder markets are viewed as non-profitable and not sustainable. However, more and more smallholders are willing to pay for veterinary products such as vaccines to protect their crucial investments. In India, smallholder farmers rearing poultry are proving that a market does exist and service provision is profitable to vaccine manufacturers, local distributors, vaccinators and even to the farmers themselves who are benefiting from the Newcastle Disease vaccine.
Porcine Cysticercosis is a serious zoonotic disease prevalent in many parts of the world especially in developing countries, where sanitation remains a challenge. It causes 30% of human epilepsy cases in the developing world.
A GALVmed-led project in Eastern Uganda is expected to significantly reduce cases of Porcine Cysticercosis in pigs and break the cycle of infection to humans. Already the project is eliciting some positive response from farmers whose pigs have been vaccinated and de-wormed using a vaccine and a dewormer developed in collaboration with our partners Indian Immunologicals Ltd, MCI Sante Animal and the University of Melbourne.